Literature DB >> 22712547

Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance.

N Phelan1, A O'Connor, T Kyaw Tun, N Correia, G Boran, H M Roche, J Gibney.   

Abstract

OBJECTIVES: Low-grade chronic inflammation predicts cardiovascular outcomes and is observed in women with polycystic ovary syndrome (PCOS). Whether this is entirely a cause or consequence of insulin resistance (IR) is unknown.
METHODS: Seventy pairs of women with and without PCOS, matched for age, body mass index (BMI) and IR (HOMA, QUICKI and Avignon index), were generated from a larger cohort of 103 women with and 104 BMI-matched women without PCOS. Women with PCOS were studied in the follicular phase of the menstrual cycle. White cell count (WCC), high-sensitivity CRP (hsCRP) and a series of 12 cytokines and growth factors were measured. These inflammatory markers were also compared between women with PCOS and 10 normal women studied in the follicular, peri-ovulatory and luteal stages.
RESULTS: When all subjects were compared, WCC (6.75 × 10(9) vs 5.60 × 10(9 ) g/l, P < 0.005), hsCRP (4.04 vs 2.90 mg/l, P < 0.05) and IL-6 (1.11 vs 0.72 pg/ml, P < 0.05) were greater in women with PCOS. Pair-matching for IR eliminated between-group differences in hsCRP and cytokines but did not alter the difference in WCC (6.60 × 10(9) vs 5.60 × 10(9 ) g/l, P < 0.005). WCC was greater in PCOS compared to normal women at all stages of the menstrual cycle.
CONCLUSIONS: Low-grade inflammation occurs in PCOS. Increased hsCRP and cytokines are associated with IR, but increased WCC is observed even when IR is accounted for. The explanation for this and its clinical significance is unknown.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 22712547     DOI: 10.1111/j.1365-2265.2012.04454.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.

Authors:  M A Yilmaz; C Duran; M Basaran
Journal:  J Endocrinol Invest       Date:  2015-06-23       Impact factor: 4.256

Review 2.  Is cardiorespiratory fitness impaired in PCOS women? A review of the literature.

Authors:  S Donà; E Bacchi; P Moghetti
Journal:  J Endocrinol Invest       Date:  2016-12-27       Impact factor: 4.256

3.  Gender- and Age-Specific Associations between Visceral Obesity and Renal Function Impairment.

Authors:  Yu-Chung Tsao; Jau-Yuan Chen; Wei-Chung Yeh; Wen-Cheng Li
Journal:  Obes Facts       Date:  2019-02-06       Impact factor: 3.942

4.  Downregulation of MicroRNA-222 Reduces Insulin Resistance in Rats with PCOS by Inhibiting Activation of the MAPK/ERK Pathway via Pten.

Authors:  Hong Ye; Xiu-Juan Liu; Yan Hui; Yang-Huan Liang; Cai-Hong Li; Qiong Wan
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-10       Impact factor: 8.886

5.  MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.

Authors:  Dan-Ni Zhou; Sai-Jiao Li; Jin-Li Ding; Tai-Lang Yin; Jing Yang; Hong Ye
Journal:  Curr Med Sci       Date:  2018-10-20

Review 6.  The hematologic consequences of obesity.

Authors:  Johanna C Purdy; Joseph J Shatzel
Journal:  Eur J Haematol       Date:  2020-12-13       Impact factor: 2.997

7.  Gender- and Age-Specific Associations Between Body Fat Composition and C-Reactive Protein with Lung Function: A Cross-Sectional Study.

Authors:  Yu-Chung Tsao; Yi-Yen Lee; Jau-Yuan Chen; Wei-Chung Yeh; Chung-Hsun Chuang; Wei Yu; Wen-Cheng Li
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

8.  MicroRNA-29c-3p participates in insulin function to modulate polycystic ovary syndrome via targeting Forkhead box O 3.

Authors:  HongXia Chen; YunFeng Fu; ZiXiang Guo; XiaoDong Zhou
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

9.  Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Zheng Peng; Yifan Sun; Xiaolan Lv; Hongyu Zhang; Chunming Liu; Shengming Dai
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  Inflammatory Markers in Women with Polycystic Ovary Syndrome.

Authors:  E Rudnicka; M Kunicki; K Suchta; P Machura; M Grymowicz; R Smolarczyk
Journal:  Biomed Res Int       Date:  2020-03-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.